Stroke risk in women across the life course

This piece is for general information and discussion only. It is not medical or legal advice.

1. Why stroke risk in women matters

Stroke is a major cause of mortality and long‑term disability in the UK and a significant contributor to years of life lost. More people are living with stroke as the population ages, and women form a growing proportion of survivors in the oldest age groups.

Although men have higher incidence earlier in life, women typically live longer and accumulate more vascular risk factors with age. Women also experience unique risk exposures during pregnancy, menopause and through hormonal medication. Because stroke intersects with maternity safety, cardiovascular prevention, rehabilitation, social care and employment, national strategies increasingly recognise the need to understand sex differences across the life course.

2. Evidence and policy

National guidance sets expectations for rapid assessment, urgent imaging and secondary prevention in suspected stroke and TIA. The National Clinical Guideline for Stroke outlines standards spanning pre‑hospital identification, acute intervention, rehabilitation and long‑term support.

The National Stroke Service Model describes how stroke services should be organised, including hyperacute stroke units, integrated stroke delivery networks and community rehabilitation. National improvement programmes have highlighted substantial variation in access to CT/MRI, thrombectomy and specialist stroke units across England.

Public health profiles show major variation in risk factor prevalence and stroke outcomes between regions. Reports from professional bodies and patient organisations highlight ongoing inequalities, including higher stroke burden in more deprived communities.

International research confirms consistent sex differences: women experience more strokes over the life course, present at older ages and frequently have greater post‑stroke disability. National investigations have reported ongoing delays in recognising stroke, particularly in people with atypical presentations.

3. Age and sex patterns in women

Stroke risk increases steeply with age. In women:

Younger adulthood: overall risk is low, but factors such as migraine with aura, smoking, hormonal contraception and pregnancy‑related complications can influence risk.
Midlife: blood pressure, lipid profiles and metabolic risk often change, and the prevalence of hypertension, diabetes and atrial fibrillation rises.
Older age: women make up the majority of stroke survivors after age 75. Many live alone, experience frailty or cognitive impairment, or have sensory loss, all of which affect recognition and timely access to emergency care.

Women are also more likely to present with non‑focal or “atypical” symptoms such as acute confusion, dizziness or generalised weakness. These presentations intersect with broader structural factors including deprivation, ethnicity and access to urgent assessment. Women from Black and South Asian backgrounds, and women in more deprived areas, face higher vascular risk and may encounter additional barriers to care.

4. Pregnancy, birth and the postnatal year

Neurological conditions, including stroke, are a leading indirect cause of maternal death. National maternity policy highlights the need for improved recognition of neurological symptoms during pregnancy and the first postnatal year.

Pregnancy‑associated stroke is uncommon but carries significant risk when it occurs. Hypertensive disorders of pregnancy, cerebral venous thrombosis and certain haemorrhagic strokes are more common during pregnancy and shortly after birth than in non‑pregnant women of the same age.

Maternal mortality reviews frequently describe delays in recognising severe headache, visual changes, seizures, focal neurological deficits or very high blood pressure. Symptoms may be attributed to anxiety, musculoskeletal pain or normal pregnancy changes.

The early postnatal period is characterised by heightened thrombotic risk that can persist for weeks to months. This can interact with pre‑existing vascular risk factors, caesarean birth, multiple pregnancy and limited opportunities for follow‑up.

5. How diagnostic assessment is generally approached

Guidance frames stroke as a time‑critical emergency requiring rapid exploration of neurological change and early imaging. Assessment usually involves understanding the timeline of symptoms such as weakness, visual loss, speech disturbance, collapse or confusion. In women, clinicians also consider pregnancy status, past hypertensive pregnancy disorders, migraine with aura, hormonal medication use and previous episodes of high blood pressure or palpitations.

Physical examination often includes neurological assessment, blood pressure measurement, pulse regularity and level of consciousness. In maternity settings, clinicians also assess for signs of hypertensive disorders.

Investigations include urgent CT head to distinguish haemorrhagic from ischaemic stroke, CT angiography to detect large‑vessel occlusions and MRI where needed. Venography may be used when cerebral venous thrombosis is suspected.

Routine investigations often include full blood count, electrolytes, glucose, coagulation studies and lipid profiles, with pregnancy‑related tests added where appropriate. ECG and extended rhythm monitoring are used to identify atrial fibrillation. In selected cases, echocardiography or tests for autoimmune or thrombotic conditions may be used.

System reviews repeatedly identify delays in obtaining imaging, variation in access to thrombectomy and inconsistent use of prolonged rhythm monitoring. These delays disproportionately affect women who present with atypical symptoms or who are pregnant or postnatal. Many women report that their symptoms were initially attributed to stress, migraine, viral illness or anxiety.

6. What women commonly report raising

In qualitative research, national audits and patient testimony, women often report that sudden neurological symptoms were initially interpreted as benign. Some describe presenting with severe headache, dizziness, weakness or confusion and being told they were stressed, tired or experiencing migraine.

Women frequently describe previous episodes of high blood pressure or palpitations that were not followed up. Difficulties in accessing urgent assessment, long waits for review, and uncertainty over whom to contact at the point of symptom onset are recurring themes.

Communication gaps between ambulance, emergency, stroke and maternity services are also commonly described. Issues around unclear explanations, limited discussion of prognosis, and limited opportunities to ask questions about work, driving, caring responsibilities and future pregnancy are repeatedly highlighted.

7. System watchpoints

This section summarises themes highlighted in national reviews. It is not medical or legal advice.

Evidence base: Much of the data comes from hospital populations, potentially under‑representing people who do not reach hospital, those with mild or transient symptoms, care home residents and people who do not speak English fluently. Earlier research also under‑represented older women and women from minority ethnic groups.

Detection and monitoring: Blood pressure, atrial fibrillation and diabetes remain under‑detected in some areas. Maternal mortality reviews identify missed opportunities to act on very high blood pressure and neurological symptoms during pregnancy and in the first postnatal year.

Digital design and triage: Decision‑support tools and triage systems are often developed around typical stroke presentations, which may not reflect the atypical symptoms more commonly seen in women.

Transitions of care: Delays may occur at multiple points including ambulance handover, imaging access and transfer to specialist stroke units. Availability of thrombectomy varies across England.

Communication and follow‑up: Investigations frequently describe unclear medication plans, limited information about recovery and uneven coordination between teams. Women often describe wanting clearer information about return to work, caring responsibilities and future pregnancy.

8. What is improving

National stroke guidance provides a consistent framework for rapid assessment, urgent imaging, specialist care and secondary prevention. National improvement initiatives are working to expand hyperacute stroke capacity and reduce unwarranted regional variation.

Public health reporting increasingly includes sex‑specific analysis. Research into sex differences in stroke continues to expand. Maternity safety programmes recognise neurological conditions as key contributors to maternal morbidity and mortality, strengthening the focus on early recognition in pregnancy and the postnatal year.

9. Where further improvement might come from

Potential areas for improvement include more consistent implementation of stroke guidelines, stronger integration of sex‑specific and pregnancy‑related risk factors into diagnostic tools, greater training on atypical presentations, improved coordination between stroke and postnatal pathways, and more accessible information for women about recovery, work, caregiving and future reproductive plans.

10. Questions for readers

For clinicians and managers

How well do local pathways recognise atypical or non‑focal presentations?
How are pregnancy history and sex‑specific risk factors used in risk assessment?
How is performance against imaging and treatment time standards monitored across demographic groups?
How do ambulance, emergency, stroke and maternity teams communicate during transitions of care?
How are stroke survivors involved in shaping information and follow‑up services?

For patients, families and communities

How clear is the information you have received about blood pressure and stroke symptoms?
Have you ever been unsure who to contact when sudden neurological symptoms occurred?
Do routine appointments allow discussion of new or changing symptoms?
What practical barriers make it difficult to seek urgent help?
How understandable does the stroke pathway feel after hospital discharge?

Mandatory disclaimer

This article is for general information and discussion only. It is not medical or legal advice, nor a substitute for professional advice. To contribute ideas or corrections, please email womenshealthproject@outlook.com. Please do not share personal data. Individual cases cannot be reviewed. This project does not offer legal services or individual advocacy.

References

Bushnell C, Chaturvedi S, Gage KR, et al. Sex differences in stroke. Stroke (AHA/ASA Scientific Statement).
GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke. Lancet Neurology.
Intercollegiate Stroke Working Party. National Clinical Guideline for Stroke. 6th ed. Royal College of Physicians; 2023.
MBRRACE‑UK. Saving Lives, Improving Mothers’ Care. National Perinatal Epidemiology Unit.
NHS England. National Stroke Service Model. 2021.
NHS England. Three‑Year Delivery Plan for Maternity and Neonatal Services. 2023.
NHS England & Getting It Right First Time. Stroke: National Specialty Report.
NICE. Stroke and transient ischaemic attack in over 16s: NG128.
Office for Health Improvement and Disparities (OHID). CVD Profiles: Stroke and TIA.
Parliamentary and Health Service Ombudsman. Stroke Care: Learning from NHS Complaints.
Peters SAE, Woodward M. Sex differences in stroke epidemiology. Nature Reviews Neurology.
Stroke Association. State of the Nation: Stroke Statistics.